Senior​/Executive Director - Dermatology Portfolio Medical Affairs

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life‑changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first.

We’re looking for people who are determined to make life better for people around the world.

As a Clinical Research Physician specializing in Dermatology within Medical Affairs, you will provide critical medical expertise and leadership for Lilly's dermatology portfolio. This role focuses on scientific and medical strategy, evidence generation, and communication of clinical data to support patient access and appropriate use of our innovative dermatological treatments.

The CRP works closely with the global Development teams, Therapeutic Area Program Phase, Early Phase/Clinical Pharmacology, and Translational Medicine teams in new product development activities over the entire spectrum of drug development and clinical trial phases.

• Developing or contributing to the global and/or regional clinical/medical plan.
• Development, conduct and reporting of local clinical trials.
• Implementation of global clinical trials conducted in local affiliates/countries.
• Reporting of adverse events as mandated by corporate patient safety.
• Review process for protocols, study reports, publications and data dissemination for products, new and updated labels, documents and tools supporting product pricing, reimbursement, and access (PRA), grant submissions and contracts.
• Contacts with regulatory and other governmental agencies.
• Outreach aimed at the external clinical customer community, including thought leaders.
• Various medical activities in support of demand realization.

Primary Responsibilities:

The primary responsibility of the Medical Affairs CRP is to provide expert medical leadership and support to all aspects of the local business, to ultimately enhance the customers' experience and develop medical strategies that improve patient outcomes. This includes informing the identification of Clinical Care Gaps (CCG), Integrated Evidence Generation (IEG) planning, product lifecycle planning, and evidence dissemination plans aligned with medical strategy.

The CRP provides local marketed product support (informing the development of the "patient journey" and the strategic plan for the compound), medical support for regulatory affairs and interactions with government agencies (medical support for New and Supplemental New Drug Submissions and participating and presenting at meetings with government regulatory agencies), medical support for pricing, reimbursement and access (PRA), providing medical guidance on the PRA plan and interacting with government PRA agencies as needed), and leading in local scientific data dissemination (leading and presenting at conferences, advisory boards, etc.,

and overseeing the development of the scientific content of educational programs).

These responsibilities are generally related to late phase and marketed compounds but can also include early phase trials (for example, phase I and II trials). The CRP is responsible for collaborating with the global teams in the planning, startup and conduct of phase 3b/4 studies (and phase I and II studies where applicable), as well as non‑clinical trial solutions/activities that are conducted in affiliates/countries as described in the clinical plan.

• Medical Doctor or Doctor of Osteopathy. Must be board eligible or certified in appropriate specialty/subspecialty or have completed the comparable level of post‑medical school clinical training relevant to the country of hiring. US trained physicians must have achieved board eligibility or certification. Physicians trained outside the US who are not US board eligible or certified may be hired directly for employment in the US at the discretion of the Chief Medical Officer.
• Non-US trained physicians must have completed…